Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson at Barclays Global Consumer Staples Conference Transcript

Sep 10, 2021 / 01:20PM GMT
Release Date Price: R$58.42 (-0.53%)
Lauren Rae Lieberman
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

Next up this morning, we're pleased to welcome Johnson & Johnson. Here from the company are: Thibaut Mongon, J&J's Executive Vice President and Worldwide Chairman of Consumer; Paul Ruh, the Consumer Health CFO; and Caroline Tillett, the Head of R&D for Consumer Health.

We're going to start out with the company sharing some prepared remarks and then I'll moderate the Q&A session. So with that, let's get right to it, and over to you, Thibaut.

Thibaut Mongon
Johnson & Johnson - Executive VP & Worldwide Chairman of Consumer Health

Thank you, Lauren, and good morning, everyone. I'm really delighted to be here again this year to speak with you about Johnson & Johnson Consumer Health. As always, please refer to this slide or our website to reference our SEC filings and information regarding any forward-looking statements that may be made during this presentation.

So now let's get started. You know Johnson & Johnson, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot